Foresite Capital Management II as of June 30, 2015
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 21 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aduro Biotech | 22.4 | $64M | 2.1M | 30.33 | |
| Adaptimmune Therapeutics Sponsored Adr (ADAP) | 11.3 | $32M | 1.8M | 18.33 | |
| Universal American | 10.0 | $29M | 2.8M | 10.12 | |
| Zafgen | 9.9 | $28M | 811k | 34.63 | |
| Epizyme | 7.6 | $22M | 898k | 24.00 | |
| Orexigen Therapeutics | 7.5 | $21M | 4.3M | 4.95 | |
| Alder Biopharmaceuticals | 6.4 | $18M | 345k | 52.97 | |
| Aerie Pharmaceuticals | 5.0 | $14M | 805k | 17.65 | |
| Regulus Therapeutics | 3.4 | $9.8M | 894k | 10.96 | |
| Ardelyx | 2.9 | $8.3M | 517k | 15.97 | |
| Nanostring Technologies (NSTGQ) | 2.5 | $7.2M | 465k | 15.42 | |
| BioDelivery Sciences International | 2.0 | $5.7M | 712k | 7.96 | |
| Scynexis | 1.9 | $5.5M | 628k | 8.79 | |
| Juno Therapeutics | 1.7 | $4.9M | 92k | 53.33 | |
| Quotient SHS | 1.5 | $4.4M | 298k | 14.79 | |
| Biotie Therapies Corp. Sponsored Adr | 1.3 | $3.8M | 189k | 19.97 | |
| Nexvet Biopharma public limited company Ord Shs | 1.2 | $3.5M | 708k | 4.97 | |
| Axovant Sciences | 0.5 | $1.3M | 65k | 20.38 | |
| NeuroDerm Ord Shs | 0.4 | $1.1M | 74k | 15.35 | |
| Acceleron Pharma | 0.3 | $984k | 31k | 31.64 | |
| Agile Therapeutics | 0.2 | $428k | 50k | 8.58 |
